Cargando…

How does HbA1c predict mortality and readmission in patients with heart failure? A protocol for systematic review and meta-analysis

BACKGROUND: Accumulating evidence suggests that HbA1c levels, a common clinical indicator of chronic glucose metabolism over the preceding 2–3 months, are independent risk factors for cardiovascular disease, including heart failure. However, conflicting evidence obscures clear cutoffs of HbA1c level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jun-Peng, Zeng, Rui-Xiang, Mai, Xiao-Yi, Pan, Wen-Jun, Zhang, Yu-Zhuo, Zhang, Min-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007851/ https://www.ncbi.nlm.nih.gov/pubmed/36899409 http://dx.doi.org/10.1186/s13643-023-02179-4

Ejemplares similares

Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
por: Blecker, Saul, et al.
Publicado: (2016)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

Postal methods for monitoring HbA1c in diabetes mellitus: a protocol for systematic review
por: Colley, Jack, et al.
Publicado: (2022)

Longitudinal HbA(1c) trajectory modelling reveals the association of HbA(1c) and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus
por: Tee, Clarence, et al.
Publicado: (2023)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
por: Lin, You-Ting, et al.
Publicado: (2021)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Risk prediction models for mortality and readmission in patients with acute heart failure: A protocol for systematic review, critical appraisal, and meta-analysis
por: Zhang, Xuecheng, et al.
Publicado: (2023)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure
por: Grigg, William, et al.
Publicado: (2021)

Impact of HbA1c Measurement on Hospital Readmission Rates: Analysis of 70,000 Clinical Database Patient Records
por: Strack, Beata, et al.
Publicado: (2014)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?
por: Kochi, Ryosuke, et al.
Publicado: (2019)

Routine use of HbA1c amongst inpatients hospitalised with decompensated heart failure and the association of dysglycaemia with outcomes
por: Khoo, K., et al.
Publicado: (2018)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Recent Progress in Electrochemical HbA1c Sensors: A Review
por: Wang, Baozhen, et al.
Publicado: (2015)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Plasma HbA1c in the investigation of suspected heart failure in general practice: An audit of the 2018 NICE guidelines update
por: Paschalis, Theodoros, et al.
Publicado: (2020)

Analytical performance evaluation of the Norudia HbA(1c) assay
por: Lee, Joon Hee, et al.
Publicado: (2020)

Point-of-Care Measurements of HbA(1c): Simplicity Does Not Mean Laxity With Controls
por: Leca, Viviane, et al.
Publicado: (2012)

Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort
por: Farfán Bajaña, María José, et al.
Publicado: (2022)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study
por: Tan, Joshua Kuan, et al.
Publicado: (2023)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Contemporary risk estimates of three HbA(1c) variables in relation to heart failure following diagnosis of type 2 diabetes
por: Skrtic, Stanko, et al.
Publicado: (2017)

Differential Thermal Stability and Oxidative Vulnerability of the Hemoglobin Variants, HbA(2) and HbE
por: Chakrabarti, Abhijit, et al.
Publicado: (2013)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization
por: DeVore, Adam D., et al.
Publicado: (2014)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

Machine learning based readmission and mortality prediction in heart failure patients
por: Sabouri, Maziar, et al.
Publicado: (2023)

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
por: Tye, Sok Cin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_in7r22rtlfjfls64bc11prk2l6